BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 10961024)

  • 1. Utilization of Pectin from Okra as Binding Agent in Immediate Release Tablets.
    Owusu FWA; Boakye-Gyasi ME; Entsie P; Bayor MT; Ofori-Kwakye K
    Biomed Res Int; 2021; 2021():6002286. PubMed ID: 34888384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the potential of natural polymers from plants as tablet binder and accessing their release profiles: A comparative analysis.
    Manzar R; Massey S; Arshad L; Waqar I
    Pak J Pharm Sci; 2023 Sep; 36(5(Special)):1663-1670. PubMed ID: 38008965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biogenic Waste from Two Varieties of Plantain in Ghana Contain Pectin with Potential Binding Properties in Conventional Tablets.
    Otu DAB; Owusu FWA; Boakye-Gyasi ME; Johnson R; Acquah PGJ; Edzor-Agbo Y; Bayor MT; Archer MA
    ScientificWorldJournal; 2024; 2024():5461358. PubMed ID: 38915814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of teratogenic potentials of crude ethanolic root bark and leaf extract of Rauwolfia vomitoria (apocynaceae) on the fetal heart.
    Eluwa MA; Udoaffah MT; Vulley MB; Ekanem TB; Akpantah AO; Asuquo OA; Ekong MB
    N Am J Med Sci; 2010 Dec; 2(12):592-5. PubMed ID: 22558573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Evaluation of the Binding Strength of Okra Gum and the Drug Release Characteristics of Tablets Prepared from It.
    Hussain A; Qureshi F; Abbas N; Arshad MS; Ali E
    Pharmaceutics; 2017 Jun; 9(2):. PubMed ID: 28574438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applicability and comparative evaluation of wet granulation and direct compression technology to Rauwolfia serpentina root powder: a technical note.
    Patra ChN; Pandit HK; Singh SP; Devi MV
    AAPS PharmSciTech; 2008; 9(1):100-4. PubMed ID: 18446468
    [No Abstract]   [Full Text] [Related]  

  • 7. Stability of clozapine tablets repackaged in dose administration aids using repackaging machines.
    Emonet M; Citterio-Quentin A; Bourgeois S; Godard V; Boidin C; Barratier C; Boisramé J
    Eur J Hosp Pharm; 2024 May; ():. PubMed ID: 38816183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The profiles and tensile strength on straight roots of plants withstand transient tensile injured after self-repair.
    Wang C; Zhang X; Liu J; Wang B; Li Y; Li Q
    Sci Rep; 2020 Jul; 10(1):11468. PubMed ID: 32651422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hairy root biotechnology of Rauwolfia serpentina: a potent approach for the production of pharmaceutically important terpenoid indole alkaloids.
    Mehrotra S; Goel MK; Srivastava V; Rahman LU
    Biotechnol Lett; 2015 Feb; 37(2):253-63. PubMed ID: 25326172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmaceutical technology of Grandaxin].
    Fekete P
    Acta Pharm Hung; 1993 Mar; 63(2):67-78. PubMed ID: 8517166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of named binders in Rauwolfia vomitoria root tablets.
    Onunkwo GC
    Boll Chim Farm; 2000; 139(3):132-9. PubMed ID: 10961024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Properties of Delonix regia seed gum as a novel tablet binder.
    Adetogun GE; Alebiowu G
    Acta Pol Pharm; 2009; 66(4):433-8. PubMed ID: 19702177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cation content of certain ammoniomethacrylate copolymers type A (RL) and B (RS) on their binder property in tableting.
    Uhumwangho MU; Okor RS; Eichie FE
    Acta Pol Pharm; 2004; 61(4):255-8. PubMed ID: 15575590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of Rauwolfia vomitoria and chlorpromazine on locomotor behaviour and anxiety in mice.
    Bisong SA; Brown R; Osim EE
    J Ethnopharmacol; 2010 Oct; 132(1):334-9. PubMed ID: 20800668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of oleo-gum resin as directly compressible tablet excipient and release retardant.
    Kumar P; Singh I
    Acta Pol Pharm; 2010; 67(3):307-13. PubMed ID: 20524434
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.